Conversely, antibody blockade of IL-8/IL-8R markedly reduces the expression of mesenchymal markers, decreases recruitment of MDSCs, and enhances immune-mediated lysis of tumor cells [23, 27]. The gene discussed is CXCL8; the disease is neoplasm.